Dr. Heidi Putt, DO

NPI: 1114969888
Total Payments
$1,032
2024 Payments
$22.11
Companies
12
Transactions
56
Medicare Patients
1,525
Medicare Billing
$181,455

Payment Breakdown by Category

Food & Beverage$1,032 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,032 56 100.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $397.09 22 $0 (2023)
Medtronic, Inc. $144.95 1 $0 (2023)
Janssen Biotech, Inc. $133.16 10 $0 (2019)
PFIZER INC. $99.86 7 $0 (2020)
Takeda Pharmaceuticals U.S.A., Inc. $87.22 5 $0 (2019)
Intercept Pharmaceuticals, Inc. $39.30 3 $0 (2019)
UCB, Inc. $36.46 2 $0 (2018)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $24.47 2 $0 (2020)
Lilly USA, LLC $22.11 1 $0 (2024)
Shire North American Group Inc $20.08 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $22.11 1 Lilly USA, LLC ($22.11)
2023 $228.15 2 Medtronic, Inc. ($144.95)
2022 $47.83 1 ABBVIE INC. ($47.83)
2021 $13.26 1 Celgene Corporation ($13.26)
2020 $39.63 3 PFIZER INC. ($28.16)
2019 $247.79 17 Janssen Biotech, Inc. ($64.33)
2018 $238.67 16 AbbVie, Inc. ($81.37)
2017 $194.13 15 AbbVie, Inc. ($120.49)

All Payment Transactions

56 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
06/12/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $22.11 General
Category: Immunology
11/07/2023 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $83.20 General
Category: IMMUNOLOGY
03/24/2023 Medtronic, Inc. GI GENIUS (Device) Food and Beverage In-kind items and services $144.95 General
Category: Gastrointestinal AI
09/28/2022 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $47.83 General
Category: IMMUNOLOGY
06/14/2021 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $13.26 General
Category: Neuroscience
09/23/2020 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $11.47 General
Category: GASTROENTEROLOGY
02/24/2020 PFIZER INC. XELJANZ (Drug), INFLECTRA Food and Beverage In-kind items and services $16.34 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
01/13/2020 PFIZER INC. XELJANZ (Drug), INFLECTRA Food and Beverage In-kind items and services $11.82 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
12/10/2019 AbbVie, Inc. Humira (Biological) Food and Beverage In-kind items and services $22.73 General
Category: Immunology
12/04/2019 PFIZER INC. XELJANZ (Drug), INFLECTRA Food and Beverage In-kind items and services $14.33 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
11/25/2019 Intercept Pharmaceuticals, Inc. OCALIVA (Drug) Food and Beverage In-kind items and services $14.67 General
Category: HEPATOLOGY GASTROENTEROLOGY
10/23/2019 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $11.91 General
Category: Immunology
10/22/2019 PFIZER INC. XELJANZ (Drug), INFLECTRA Food and Beverage In-kind items and services $16.90 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
09/25/2019 Takeda Pharmaceuticals U.S.A., Inc. Entyvio (Biological) Food and Beverage In-kind items and services $16.48 General
Category: Lower GI
09/23/2019 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $13.00 General
Category: GASTROENTEROLOGY
09/12/2019 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $11.75 General
Category: Immunology
08/29/2019 PFIZER INC. XELJANZ (Drug), INFLECTRA Food and Beverage In-kind items and services $12.40 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
08/07/2019 AbbVie, Inc. Humira (Biological) Food and Beverage In-kind items and services $13.62 General
Category: Immunology
06/19/2019 Janssen Biotech, Inc. STELARA (Biological), SIMPONI Food and Beverage In-kind items and services $12.68 General
Category: Immunology
06/05/2019 Janssen Biotech, Inc. STELARA (Biological), SIMPONI Food and Beverage In-kind items and services $12.95 General
Category: Immunology
05/01/2019 PFIZER INC. XELJANZ (Drug), INFLECTRA Food and Beverage In-kind items and services $15.76 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
04/23/2019 Takeda Pharmaceuticals U.S.A., Inc. Food and Beverage In-kind items and services $15.72 General
03/06/2019 AbbVie, Inc. Humira (Biological) Food and Beverage In-kind items and services $14.77 General
Category: Immunology
02/06/2019 AbbVie, Inc. Creon (Drug) Food and Beverage In-kind items and services $13.08 General
Category: Endocrinology
01/17/2019 Janssen Biotech, Inc. STELARA (Biological), SIMPONI Food and Beverage In-kind items and services $15.04 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 315 362 $127,717 $38,627
2022 9 320 355 $113,399 $36,441
2021 11 450 507 $216,905 $54,021
2020 10 440 527 $204,801 $52,365
Total Patients
1,525
Total Services
1,751
Medicare Billing
$181,455
Procedure Codes
39

All Medicare Procedures & Services

39 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 61 61 $37,515 $11,636 31.0%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 39 42 $14,700 $5,392 36.7%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 65 69 $23,115 $5,074 22.0%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 34 65 $8,190 $3,960 48.4%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 22 22 $9,900 $3,870 39.1%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 43 43 $20,941 $3,693 17.6%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 14 14 $6,314 $2,468 39.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 25 33 $6,171 $2,034 33.0%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 12 13 $871.00 $499.07 57.3%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 61 64 $22,400 $9,530 42.5%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 32 32 $19,680 $6,306 32.0%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 70 71 $23,785 $5,610 23.6%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 57 83 $10,458 $4,555 43.6%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 15 15 $6,750 $2,682 39.7%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2022 22 22 $9,900 $2,618 26.4%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 26 26 $12,662 $2,314 18.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 23 27 $5,049 $1,645 32.6%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 14 15 $2,715 $1,182 43.5%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 93 96 $31,695 $15,195 47.9%
45385 Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare Facility 2021 42 43 $41,242 $7,999 19.4%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 81 120 $13,538 $6,875 50.8%
45380 Biopsy of the large bowel using an endoscope (colonoscopy) Facility 2021 55 56 $41,369 $6,193 15.0%
43239 Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope Facility 2021 69 69 $42,793 $5,928 13.9%
45378 Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk Facility 2021 29 29 $20,262 $3,434 16.9%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2021 15 15 $8,650 $2,741 31.7%

About Dr. Heidi Putt, DO

Dr. Heidi Putt, DO is a Internal Medicine healthcare provider based in Wyoming, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114969888.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Heidi Putt, DO has received a total of $1,032 in payments from pharmaceutical and medical device companies, with $22.11 received in 2024. These payments were reported across 56 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,032).

As a Medicare-enrolled provider, Putt has provided services to 1,525 Medicare beneficiaries, totaling 1,751 services with total Medicare billing of $181,455. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Gastroenterology
  • Location Wyoming, MI
  • Active Since 06/10/2006
  • Last Updated 05/27/2025
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1114969888

Products in Payments

  • Humira (Biological) $204.48
  • GI GENIUS (Device) $144.95
  • STELARA (Biological) $133.16
  • XELJANZ (Drug) $99.86
  • SKYRIZI (Biological) $83.20
  • Entyvio (Biological) $71.50
  • Creon (Drug) $61.58
  • RINVOQ (Biological) $47.83
  • Cimzia (Drug) $36.46
  • OCA (Drug) $24.63
  • XIFAXAN (Drug) $24.47
  • OMVOH (Drug) $22.11
  • GATTEX (Drug) $20.08
  • OCALIVA (Drug) $14.67
  • ZEPOSIA (Drug) $13.26

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Wyoming